Wichita Investments   EP 1   Introduction to  SPAC  Investments
Channel: Dalton Graham
Date: 17/02/2021

I created this brief introduction on SPAC's because my life journey has brought me down a unique path that has provided me an intimate understanding of revolutionary medicine/therapeutic advancements through the utilization of Stem Cells. In the case of the SPAC merger I will use as the example company in this presentation, Placental Derived Stem Cells and the life time culmination of work of Dr. Robert Hariri, Founder and CEO of Celularity, Inc.

GX Acquistions will be merging with Celularity to bring the company public in 2Q2021 (March/April)

Currently at the time of upload, the SPAC GXGX is selling common shares for roughly $10.15 per share. I see TRMENDOUS upside and VERY LIMITED downside potential.

Upon finalization of the merger, GXGX will become CELU (Celularity)

The intent of this video is to help newer investors understand the various ways they can maximize their financial positions with regard to SPAC offerings pre merger.

Thank you, and please don't stop here. Go listen to the good doctor!
Jan 26th 2021: https://youtu.be/tjk4hsNH25E

Oct 9th, 2019: https://youtu.be/SNmvHjtn12c

My Due Diligence report on Celularity: https://docs.google.com/document/d/1OEZDZ__hzuAk3lzY6kWCuIoNQElAJWmFS-saX0cOeTU/edit?usp=sharing